Potential use of pentoxifylline in cancer therapy

G Golunski, A Woziwodzka… - Current pharmaceutical …, 2018 - ingentaconnect.com
Background: Pentoxifylline (PTX) is a drug commonly used in the treatment of intermittent
claudication. However, numerous research groups report that PTX also may potentially be …

Parsimonious Effect of Pentoxifylline on Angiogenesis: A Novel Pentoxifylline-Biased Adenosine G Protein-Coupled Receptor Signaling Platform

W Khoury, R Trus, X Chen, L Baghaie, M Clark… - Cells, 2023 - mdpi.com
Angiogenesis is the physiological process of developing new blood vessels to facilitate the
delivery of oxygen and nutrients to meet the functional demands of growing tissues. It also …

[HTML][HTML] Celastrol inhibits lung cancer growth by triggering histone acetylation and acting synergically with HDAC inhibitors

G Chen, X Zhu, J Li, Y Zhang, X Wang, R Zhang… - Pharmacological …, 2022 - Elsevier
Alterations in histone modification have been linked to cancer development and
progression. Celastrol, a Chinese herbal compound, shows potent anti-tumor effects through …

A systematic framework for drug repositioning from integrated omics and drug phenotype profiles using pathway‐drug network

E Jadamba, M Shin - BioMed research international, 2016 - Wiley Online Library
Drug repositioning offers new clinical indications for old drugs. Recently, many
computational approaches have been developed to repurpose marketed drugs in human …

Pentoxifylline changes the balance of immune cell population in breast tumor-infiltrating lymphocytes

MH Kazemi, M Shokrollahi Barough… - Medical Oncology, 2023 - Springer
Immunotherapy utilizing tumor-infiltrating lymphocytes (TILs) is a promising approach for
cancer treatment. Pentoxifylline (PTXF), a xanthine derivative, exhibits antitumor properties …

[PDF][PDF] Decrease of tumor-infiltrating regulatory T cells using pentoxifylline: An ex vivo analysis in triple-negative breast cancer mouse model

MH Kazemi, MS Barough, A Ghanavatinejad… - Iranian Journal of …, 2022 - ijaai.tums.ac.ir
Triple-negative breast cancer (TNBC) is the most aggressive type of BC with the highest
percentage of tumor-infiltrating lymphocytes (TILs). Hence, TIL therapy is considered a …

Strategic endothelial cell tube formation assay: comparing extracellular matrix and growth factor reduced extracellular matrix

D Xie, D Ju, C Speyer, D Gorski… - Journal of visualized …, 2016 - pmc.ncbi.nlm.nih.gov
Malignant tumors require a blood supply in order to survive and spread. These tumors
obtain their needed blood from the patient's blood stream by hijacking the process of …

Entinostat reverses cisplatin resistance in esophageal squamous cell carcinoma via down-regulation of multidrug resistance gene 1

XP Huang, X Li, MY Situ, LY Huang, JY Wang, TC He… - Cancer letters, 2018 - Elsevier
Cisplatin resistance frequently occurs in esophageal squamous cell carcinoma (ESCC). The
underlying mechanism for cisplatin resistance in ESCC remains largely obscure. Here we …

MS‐275 potentiates the effect of YM‐155 in lung adenocarcinoma via survivin downregulation induced by miR‐138 and miR‐195

BL Luo, Y Zhou, H Lv, SH Sun, WX Tang - Thoracic Cancer, 2019 - Wiley Online Library
Background YM‐155 has been proven to be an efficient antitumor suppressor in non‐small
cell lung cancer (NSCLC) cells. However, the suppressive effect of YM‐155 on the …

Combination of pentoxifylline and α-galactosylceramide with radiotherapy promotes necro-apoptosis and leukocyte infiltration and reduces the mitosis rate in murine …

RL Madera-Sandoval, J Tóvári, J Lövey, I Ranđelović… - Acta …, 2019 - Elsevier
Despite the success for the treatment of melanoma such as targeted molecular therapy, the
use of such treatments are expensive For this reason, this study was carried out to explore …